-
A new report points to a decline in heart disease and stroke deaths, but cardiovascular disease remains the top cause of death in the U.S. Lifestyle changes could delay or prevent about 70% of cases.
-
Will it be a year of "fractured resilience"? Or "pragmatic empathy"? Will "MOUs" be the next global health strategy? Are we in a new age of "decolonization" — or of "localization"?
-
Estimates show that nearly five million Americans are slated to lose health insurance this year, as enhanced Obamacare subsidies end.
-
The U.S. is the only country allowed to withdraw from the World Health Organization. And Jan. 22 is the day when Trump's pullout announcement should go into effect. But ... it's complicated.
-
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model for all gene therapies being developed.
-
Cases of the flu have started to decline, according to the CDC, but flu season isn't over yet. We bust some common myths on ways to avoid catching the virus.
-
The cancer drug leucovorin has been in high demand since the Trump administration endorsed it as a treatment for some autistic kids. Some experts say the drug's popularity has outpaced the science.
-
New research is underway to test whether a combination of high-intensity interval training and generic medicines can slow down aging and fend off age-related diseases. Here's how it might work.
-
A doctor from Nigeria tells what Martin Luther King Jr. taught him about health, Justice and inequality.
-
ACA enrollment is down for the first time in 5 years, and people are facing enormous premium hikes. Hopes for Congress to restore funding are fading.
-
A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it looked as if it would be over before it started.
-
The Administration for a Healthy America is RFK Jr.'s plan to tackle chronic disease, addiction and other persistent problems. But so far it's not being set up like previous new agencies.